Scandinavian ChemoTech AB OMXSTO:CMOTEC_B:
CHEMOTECH'S ANIMAL CARE ANNOUNCES FIRST U.S. ORDER FROM LEADING EQUINE CLINIC IN KENTUCKY
THE PROGRAM IS STRUCTURED TO TRANSITION THROUGH A LEASE-TO-BUY ARRANGEMENT TO A PURCHASE IN 2026
Chemotech's Animal Care Announces First U.S. Order
Scandinavian ChemoTech AB on 6ix
Earlier from Scandinavian ChemoTech
- CMOTEC_B: Strong Q3 revenue growth and record Animal Care sales drive improved financials and outlook
- Scandinavian ChemoTech AB: Quarterly Trading Report 2025 Q3
- ChemoTech's Animal Care Reports Strong Q3 Sales, Surpassing Expectations Despite Seasonal Slowdown
- Chemotech's Animal Care Enters Swiss Market As Part Of DACH Expansion
- CMOTEC_B: Animal Care sales hit records and TSE tech achieved scientific validation, fueling growth
Later from Scandinavian ChemoTech
- CMOTEC_B: Revenue doubled and losses narrowed, with Animal Care driving growth and US expansion
- Scandinavian ChemoTech (Q4 Review): Seasonal softness, intact growth case
- Sweden's ChemoTech Q1 net sales rise, loss narrows on US operation improvement
- ChemoTech: Outcome Of Directed Issue
- Scandinavian Chemotech Secures SEK 6 Mln Growth Loan
Follow Scandinavian ChemoTech into a list and get an email when it puts out news.
Follow Scandinavian ChemoTech